Altimmune
ALT
$7.30
Share price
1.53%
Change (1 day)
46.59%
Change (1 year)
Categories
P/S ratio for Altimmune (ALT)
P/S ratio as of May 2024 (TTM): > 1000
According to Altimmune's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1196.57. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Altimmune from 2006 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | |
| 2022 | N/A | -100% |
| 2021 | 82.5 | 61.23% |
| 2020 | 51.2 | 926.12% |
| 2019 | 4.99 | 381.71% |
| 2018 | 1.04 | -99.86% |
| 2017 | 751 | 691.97% |
| 2016 | 94.8 | 724.33% |
| 2015 | 11.5 | 1.76% |
| 2014 | 11.3 | 108.01% |
| 2013 | 5.43 | 152.49% |
| 2012 | 2.15 | -14.87% |
| 2011 | 2.53 | -72.88% |
| 2010 | 9.32 | 365.55% |
| 2009 | 2.00 | 10.62% |
| 2008 | 1.81 | -69.82% |
| 2007 | 6.00 | -90.52% |
| 2006 | 63.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -99.91% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | -92.27% | 🇺🇸 USA |